US$ 26.26
glp 1 drugs and cancer The science around GLP-1 is suddenly getting a lot more interesting Do GLP-1s Lower Cancer Risk?
Description
Appetite Suppressants

The growing diabetes population creates a greater target market for GLP-1 receptor agonists

doi: 10.1111/dom.14280 179 LarsenPJ

J Clin Endocrinol Metab (2020) 105(8):e2695709

Targeting cAMP/PKA pathway for glycemic control and type 2 diabetes therapy
Back Madsen, OD, Karlsen, C, Blume, N, et al (1995) 'Transplantable glucagonomas derived from pluripotent rat islet tumor tissue cause severe anorexia and adipsia', Scandinavian Journal of Clinical and Laboratory Investigation Supplement , 220, 27-35
